[Uric acid, apo-E and apo-C3 correlation in normo- and hyperlipidemia]

Area of Science:

• Biochemistry
• Clinical Medicine
• Cardiovascular Research

Background:

• Lipid metabolism disorders, including hyperlipidemia, are significant risk factors for cardiovascular disease.
• Apolipoproteins, such as apo-E and apo-C3, play crucial roles in lipoprotein metabolism and transport.
• Uric acid, traditionally linked to gout, is increasingly recognized for its potential role in metabolic and cardiovascular conditions.

Purpose of the Study:

• To examine the relationship between serum uric acid levels and apolipoprotein E (apo-E) in individuals with normal lipid levels and those with hyperlipidemia.
• To investigate potential correlations between uric acid and apo-E across different lipidemic states.

Main Methods:

• Serum lipid profiles, apolipoprotein spectrum, and uric acid levels were quantified in 78 patients.
• Patients were categorized into two groups: 58 with normolipidemia and 25 with hyperlipidemia (Type IIa and IIb).
• Measurements were performed using Chronolab (Switzerland) kits.

Main Results:

• Patients with hyperlipidemia exhibited significantly higher apo-E levels compared to normolipidemic individuals.
• No significant difference in uric acid levels was observed between the two groups.
• Correlation analysis revealed a significant association between uric acid and apo-E in both groups, with a positive correlation in normolipidemia and a negative correlation in hyperlipidemia.

Conclusions:

• Hyperlipidemia induces an inversion in the correlation between uric acid, apo-E, and apo-C3 levels.
• Elevated apo-C3 levels may function as an adaptive mechanism to counteract apo-E-induced hyperlipidemia.
• These findings highlight a complex interplay between uric acid, apolipoproteins, and lipid metabolism.